Theresa M. Williams

Person

Harleysville, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds for the treatment of cancer and inflammatory disease
- Patent number 12,168,668
- Issue date Dec 17, 2024
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of cancer and inflammatory disease
- Patent number 11,560,390
- Issue date Jan 24, 2023
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that interact with the Ras superfamily for the treatment...
- Patent number 11,541,041
- Issue date Jan 3, 2023
- SHY Therapeutics LLC
- Yaron R. Hadari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that interact with the Ras superfamily for the treatment...
- Patent number 11,213,515
- Issue date Jan 4, 2022
- SHY Therapeutics LLC
- Yaron R. Hadari
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds that interact with the Ras superfamily for the treatment...
- Patent number 11,026,930
- Issue date Jun 8, 2021
- SHY Therapeutics LLC
- Yaron R. Hadari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that interact with the Ras superfamily for the treatment...
- Patent number 11,000,515
- Issue date May 11, 2021
- SHY Therapeutics LLC
- Yaron R. Hadari
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds that interact with the Ras superfamily for the treatment...
- Patent number 10,940,139
- Issue date Mar 9, 2021
- SHY Therapeutics LLC
- Yaron R. Hadari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that interact with the Ras superfamily for the treatment...
- Patent number 10,933,054
- Issue date Mar 2, 2021
- SHY Therapeutics LLC
- Yaron R. Hadari
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds for the treatment of cancer and inflammatory disease
- Patent number 10,870,657
- Issue date Dec 22, 2020
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that interact with the Ras superfamily for the treatment...
- Patent number 10,588,894
- Issue date Mar 17, 2020
- SHY Therapeutics LLC
- Yaron R. Hadari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of cancer and inflammatory disease
- Patent number 10,221,191
- Issue date Mar 5, 2019
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 8,039,460
- Issue date Oct 18, 2011
- Merck Sharp & Dohme Corp.
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic benzodiazepine CGRP receptor antagonists
- Patent number 7,947,678
- Issue date May 24, 2011
- Merck Sharp & Dohme Corp.
- Theresa M. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 7,659,264
- Issue date Feb 9, 2010
- Merck Sharp & Dohme Corp.
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 7,632,832
- Issue date Dec 15, 2009
- Merck & Co., Inc.
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 7,534,784
- Issue date May 19, 2009
- Merck Co., Inc.
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 7,491,713
- Issue date Feb 17, 2009
- Merck Co., Inc.
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzodiazepine CGRP receptor antagonists
- Patent number 7,476,665
- Issue date Jan 13, 2009
- Merck & Co., Inc.
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 7,452,903
- Issue date Nov 18, 2008
- Merck & Co., Inc.
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carboxamide spirolactam CGRP receptor antagonists
- Patent number 7,390,798
- Issue date Jun 24, 2008
- Merck & Co., Inc.
- Theresa M. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 7,235,545
- Issue date Jun 26, 2007
- Merck & Co., Inc.
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 7,205,292
- Issue date Apr 17, 2007
- Merck & Co., Inc.
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benodiazepine spirohydantoin CGRP receptor antagonists
- Patent number 7,205,293
- Issue date Apr 17, 2007
- Merck & Co., Inc.
- Ian M. Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzodiazepine CGRP receptor antagonists
- Patent number 7,196,079
- Issue date Mar 27, 2007
- Merck & Co, Inc.
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monocyclic anilide spirohydantoin CGRP receptor antagonists
- Patent number 7,192,954
- Issue date Mar 20, 2007
- Merck & Co., Inc.
- Ian M. Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 6,953,790
- Issue date Oct 11, 2005
- Merck & Co., Inc.
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of prenyl-protein transferase
- Patent number 6,610,722
- Issue date Aug 26, 2003
- Merck & Co., Inc.
- Craig A. Stump
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of prenyl-protein transferase
- Patent number 6,562,823
- Issue date May 13, 2003
- Merck & Co., Inc.
- Christopher J. Dinsmore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of prenyl-protein transferase
- Patent number 6,534,506
- Issue date Mar 18, 2003
- Merck & Co., Inc.
- Diem N. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of prenyl-protein transferase
- Patent number 6,410,534
- Issue date Jun 25, 2002
- Merck & Co., Inc.
- Christopher J. Dinsmore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT...
- Publication number 20240360141
- Publication date Oct 31, 2024
- SHY Therapeutics, LLC
- Yaron R. Hadari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Treatment of Fibrotic Disease
- Publication number 20240309015
- Publication date Sep 19, 2024
- SHY Therapeutics, LLC
- Yaron R. Hadari
- G01 - MEASURING TESTING
Information Patent Application
Methods for the Treatment of Fibrotic Disease
- Publication number 20240124483
- Publication date Apr 18, 2024
- SHY Therapeutics, LLC
- Yaron R. Hadari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for the Treatment of Cancer and Inflammatory Disease
- Publication number 20230286997
- Publication date Sep 14, 2023
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMIL...
- Publication number 20230227466
- Publication date Jul 20, 2023
- SHY Therapeutics, LLC
- Yaron R. Hadari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds that Interact with the Ras Superfamily for the Treatment...
- Publication number 20230149369
- Publication date May 18, 2023
- SHY Therapeutics LLC
- Yaron R. HADARI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compounds that Interact with the RAS Superfamily for the Treatment...
- Publication number 20230078755
- Publication date Mar 16, 2023
- SHY Therapeutics, LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT...
- Publication number 20220347162
- Publication date Nov 3, 2022
- SHY Therapeutics LLC
- Yaron R. HADARI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE
- Publication number 20220332725
- Publication date Oct 20, 2022
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT...
- Publication number 20200121660
- Publication date Apr 23, 2020
- SHY Therapeutics LLC
- Yaron R. HADARI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT...
- Publication number 20200061037
- Publication date Feb 27, 2020
- SHY Therapeutics LLC
- Yaron R. HADARI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT...
- Publication number 20200054614
- Publication date Feb 20, 2020
- SHY Therapeutics LLC
- Yaron R. HADARI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMTORY DISEASE
- Publication number 20190218229
- Publication date Jul 18, 2019
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT...
- Publication number 20190022074
- Publication date Jan 24, 2019
- SHY Therapeutics LLC
- Yaron R. HADARI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE
- Publication number 20170174699
- Publication date Jun 22, 2017
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isotopically Labeled Biaryl Urea Compounds
- Publication number 20150336948
- Publication date Nov 26, 2015
- MERCK SHARP & DOHME CORP.
- Michael D. Altman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC MGLUR5 RECEPTOR MODULATORS
- Publication number 20130210804
- Publication date Aug 15, 2013
- Neville J. Anthony
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-ALKYL PIPERIDINE MGLUR5 RECEPTOR MODULATORS
- Publication number 20120040998
- Publication date Feb 16, 2012
- Swati P. Mercer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Non-Nucleoside Reverse Transcriptase Inhibitors
- Publication number 20100168097
- Publication date Jul 1, 2010
- Scott E. Wolkenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
- Publication number 20100113421
- Publication date May 6, 2010
- Theresa M. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CGRP RECEPTOR ANTAGONISTS
- Publication number 20100113419
- Publication date May 6, 2010
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Non-Nucleoside Reverse Transcriptase Inhibitors
- Publication number 20090131494
- Publication date May 21, 2009
- Theresa M. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CGRP receptor antagonists
- Publication number 20080280857
- Publication date Nov 13, 2008
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cgrp Receptor Antagonists
- Publication number 20080125413
- Publication date May 29, 2008
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cgrp Receptor Antagonists
- Publication number 20080113966
- Publication date May 15, 2008
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cgrp Receptor Antagonists
- Publication number 20080070899
- Publication date Mar 20, 2008
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Carboxamide Spirolactam Cgrp Receptor Antagonists
- Publication number 20070293470
- Publication date Dec 20, 2007
- Theresa M. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cgrp Receptor Antagonists
- Publication number 20070287696
- Publication date Dec 13, 2007
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CGRP receptor antagonists
- Publication number 20070225272
- Publication date Sep 27, 2007
- Christopher S. Burgey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tyrosine kinase inhibitors
- Publication number 20070173525
- Publication date Jul 26, 2007
- Annette Kim
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING

Theresa M. Williams

Person

Patents Grantslast 30 patents

Compounds for the treatment of cancer and inflammatory disease

Compounds for the treatment of cancer and inflammatory disease

Compounds that interact with the Ras superfamily for the treatment...

Compounds that interact with the Ras superfamily for the treatment...

Compounds that interact with the Ras superfamily for the treatment...

Compounds that interact with the Ras superfamily for the treatment...

Compounds that interact with the Ras superfamily for the treatment...

Compounds that interact with the Ras superfamily for the treatment...

Compounds for the treatment of cancer and inflammatory disease

Compounds that interact with the Ras superfamily for the treatment...

Compounds for the treatment of cancer and inflammatory disease

CGRP receptor antagonists

Heterocyclic benzodiazepine CGRP receptor antagonists

CGRP receptor antagonists

CGRP receptor antagonists

CGRP receptor antagonists

CGRP receptor antagonists

Benzodiazepine CGRP receptor antagonists

CGRP receptor antagonists

Carboxamide spirolactam CGRP receptor antagonists

CGRP receptor antagonists

CGRP receptor antagonists

Benodiazepine spirohydantoin CGRP receptor antagonists

Benzodiazepine CGRP receptor antagonists

Monocyclic anilide spirohydantoin CGRP receptor antagonists

CGRP receptor antagonists

Inhibitors of prenyl-protein transferase

Inhibitors of prenyl-protein transferase

Inhibitors of prenyl-protein transferase

Inhibitors of prenyl-protein transferase

Patents Applicationslast 30 patents

COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT...

Methods for the Treatment of Fibrotic Disease

Methods for the Treatment of Fibrotic Disease

Compounds for the Treatment of Cancer and Inflammatory Disease

SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMIL...

Compounds that Interact with the Ras Superfamily for the Treatment...

Compounds that Interact with the RAS Superfamily for the Treatment...

COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT...

COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE

COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT...

COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT...

COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT...

COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMTORY DISEASE

COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT...

COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE

Isotopically Labeled Biaryl Urea Compounds

TRICYCLIC MGLUR5 RECEPTOR MODULATORS

2-ALKYL PIPERIDINE MGLUR5 RECEPTOR MODULATORS

Non-Nucleoside Reverse Transcriptase Inhibitors

NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

CGRP RECEPTOR ANTAGONISTS

Non-Nucleoside Reverse Transcriptase Inhibitors

CGRP receptor antagonists

Cgrp Receptor Antagonists

Cgrp Receptor Antagonists

Cgrp Receptor Antagonists

Carboxamide Spirolactam Cgrp Receptor Antagonists

Cgrp Receptor Antagonists

CGRP receptor antagonists

Tyrosine kinase inhibitors